VIRTUS
Virtus Pharmaceuticals, LLC
Trademark Registered: 2017-01-03
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86587871 |
| Registration Number | 5111954 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Kathleen A. Rheintgen |
| Attorney Docket Number | 526892-4 |
| Law Office Assigned | M80 |
| Employee Name | WHEATLEY, TRAVIS DWIGH |
Timeline
| 2011-10-01 | Date of First Use |
| 2015-04-06 | Application Filed |
| 2016-10-18 | Published for Opposition |
| 2017-01-03 | Location: PUBLICATION AND ISSUE SECTION |
| 2017-01-03 | Status: Live/Registered |
| 2017-01-03 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Virtus Pharmaceuticals, LLC |
| Address | 12 Penns Trail Newtown DE 18940 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals, namely, prescription and over-the-counter drugs for the treatment of illness, disease or deficiencies, namely, bacterial infections, treatment symptoms of seasonal, perennial and chronic allergies and the treatment of skin hives and itching associated with skin reactions, Type 2 diabetes mellitus, Treatment and prevention of osteoporosis in postmenopausal women, treatment to increase bone mass in men with osteoporosis, treatment of glucocorticoid induced osteoporosis, Treatment of Paget's Disease of bone, Treatment for the relief of discomfort associated with acute or painful musculoskeletal conditions, Treatment and management of moderate to moderately-severe pain in adults, Treatment of hypertension, Treatment of diabetic nephropathy, Treatment of dermatitis herpetiformis and leprosy, Treatment of chronic inflammatory skin disease marked by blisters, Treatment of acid indigestion, Treatment of upset stomach, Management and support for patients requiring increased folate levels, Supplementation in support of bone health, Supplementation in support of prenatal health, including, without limitation, increased folic acid, Management and support of absorption of calcium and/or functioning of calcium in the body, Treatment of Vitamin D deficiency, Supplementation in support of postnatal health, Treatment and prevention of lack of vitamins, minerals and/or fatty acids during pregnancy, Treatment and temporary relief of cough, nasal congestion, loosening of phlegm and thin bronchial secretions, Treatment and prevention of prenatal and postnatal folate deficiency, Treatment of elevated or high levels of uric acid and prevention and treatment of metabolic problems caused by kidney disease, prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets, hormone replacement therapy, Postnatal supplementation and improvement of nutritional states of women prior to conception, prevention of acidosis, stomach or bowel problems, peptic ulcers and irritable bowel syndrome, Treatment for excessive saliva production, irritable colon and bladder dysfunction, Treatment of symptoms associated with disorders of gastrointestinal tract, bladder spasms, peptic ulcer disease, diverticulitis, irritable bowel syndrome, cystitis and pancreatitis, Prevention and treatment of low blood levels of potassium, Prevention of Fetal Neural Tube Defects when pregnant, Treatment of inadequate folic acid, folate deficiency, and anemia from inadequate folic acid, Treatment of Hyperhomocysteinemia |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2015-04-09 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-04-14 | 2 NWOS I:Incoming Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2015-04-30 | 3 PARI I:Incoming Correspondence |
| TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | 2015-04-30 | 4 TAEA I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2015-07-14 | 5 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2015-07-20 | 6 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2015-07-20 | 7 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2015-07-20 | 8 GNRN O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2015-07-21 | 9 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2015-07-21 | 10 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2015-07-21 | 11 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2016-01-20 | 12 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-01-20 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-01-20 | 14 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2016-02-03 | 15 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2016-02-03 | 16 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-02-03 | 17 GNRN O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2016-07-18 | 18 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2016-07-18 | 19 ARAA I:Incoming Correspondence |
| TEAS PETITION TO REVIVE RECEIVED | 2016-08-04 | 20 PROA I:Incoming Correspondence |
| PETITION TO REVIVE-GRANTED | 2016-08-04 | 21 PETG O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2016-08-04 | 22 TROA I:Incoming Correspondence |
| NOTICE OF REVIVAL - E-MAILED | 2016-08-05 | 23 NREV E:E-Mail |
| ASSIGNED TO LIE | 2016-08-13 | 24 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-08-15 | 25 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-08-15 | 26 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2016-08-31 | 27 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2016-08-31 | 28 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2016-08-31 | 29 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2016-08-31 | 30 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-09-01 | 31 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-09-14 | 32 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-09-28 | 33 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2016-10-18 | 34 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-10-18 | 35 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2017-01-03 | 36 R.PR A:Allowance for Publication |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2017-01-11 | 37 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2017-01-11 | 38 CHAN I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2022-01-03 | 39 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2023-03-10 | 40 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-09-08 | 41 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2023-09-08 | 42 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2023-09-08 | 43 NA85 E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 